These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2862236)

  • 1. Optimization of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control.
    Bennett SL; Barry BW; Woodford R
    J Pharm Pharmacol; 1985 May; 37(5):298-304. PubMed ID: 2862236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion.
    Barry BW; Southwell D; Woodford R
    J Invest Dermatol; 1984 Jan; 82(1):49-52. PubMed ID: 6690630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of bioavailability of topical steroids: thermodynamic control.
    Woodford R; Barry BW
    J Invest Dermatol; 1982 Dec; 79(6):388-91. PubMed ID: 7142740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
    Wiedersberg S; Naik A; Leopold CS; Guy RH
    Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
    Pershing LK; Silver BS; Krueger GG; Shah VP; Skelley JP
    Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of topical steroids.
    Barry BW
    Dermatologica; 1976; 152 Suppl 1():47-65. PubMed ID: 955238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.
    Woodford R; Haigh JM; Barry BW
    Dermatologica; 1983; 166(3):136-40. PubMed ID: 6852325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation factors affecting the isomerization rate of betamethasone-17-valerate in a developmental hydrophilic cream - a HPLC and microscopy based stability study.
    Byrne J; Wyraz A; Velasco-Torrijos T; Reinhardt R
    Pharm Dev Technol; 2017 Jun; 22(4):537-544. PubMed ID: 26895450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream.
    Magnus AD; Haigh JM; Kanfer I
    Dermatologica; 1981; 163(4):331-7. PubMed ID: 7308554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
    Poelman MC; Leveque JL; Le Gall F
    Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propylene glycol on ibuprofen absorption into human skin in vivo.
    Herkenne C; Naik A; Kalia YN; Hadgraft J; Guy RH
    J Pharm Sci; 2008 Jan; 97(1):185-97. PubMed ID: 17497726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin.
    Barry BW; Bennett SL
    J Pharm Pharmacol; 1987 Jul; 39(7):535-46. PubMed ID: 2886623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and activity of topical corticosteroids from a novel drug delivery system, the aerosol quick-break foam.
    Woodford R; Barry BW
    J Pharm Sci; 1977 Jan; 66(1):99-103. PubMed ID: 319219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of topical corticosteroids through human epidermis.
    Osamura H
    J Dermatol; 1982 Feb; 9(1):45-58. PubMed ID: 7047607
    [No Abstract]   [Full Text] [Related]  

  • 16. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action.
    Yamane MA; Williams AC; Barry BW
    J Pharm Pharmacol; 1995 Dec; 47(12A):978-89. PubMed ID: 8932680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of serial dilution of betamethasone-17-valerate on blanching potential and chemical stability.
    Ryatt KS; Cotterill JA; Mehta A
    J Clin Hosp Pharm; 1983 Jun; 8(2):143-5. PubMed ID: 6875011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of formulation factors on penetration of hydrocortisone through mouse skin.
    Shahi V; Zatz JL
    J Pharm Sci; 1978 Jun; 67(6):789-92. PubMed ID: 660457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of drugs through the skin.
    Stoughton RB
    Dermatologica; 1976; 152 Suppl 1():27-36. PubMed ID: 133842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the vehicle formulation on the stratum corneum penetration characteristics of clobetasol 17-propionate in vivo.
    Watson WS; Finlay AY
    Br J Dermatol; 1988 Apr; 118(4):523-30. PubMed ID: 3377973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.